Ionis Pharmaceuticals | IONS - DÍVIDA





DÍVIDA Alterar Data
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Arrowhead Research USD 366.28M 13.25M 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Celltrion KRW 171.09B 2.05T 2025-06
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Exelixis USD 176.46M 3.38M 2025-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Moderna USD 734M 7M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.64B 1.37B 2025-06
Omeros USD 442.16M 199K 2023-09
OPKO Health USD 395.42M 320K 2025-09
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 60.85B 78M 2025-09
Pharma Mar EUR 49.42M 1.98M 2025-12
PTC Therapeutics USD 2.71B 2.42B 2025-12
Qiagen NV USD 1.81B 314.82M 2025-12
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Sartorius EUR 4.28B 372.9M 2025-12
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tilray USD 640.95M 35.17M 2022-06
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Zz Pientze Pharmaceu CNY 1.07B 52.69M 2025-06